HK Stock Market Move | ZYLOXTB (02190) rose nearly 7% during trading, with strong sales growth in core products. The company expects annual net profit to increase nearly 1.4 times year-on-year.
Guichuang Tongqiao (02190) rose nearly 7% during the trading day, as of the time of writing, it rose 5.65% to HK$25.04, with a turnover of HK$1788.45 million.
ZYLOXTB (02190) rose nearly 7% during trading hours, and at the time of writing, it was up 5.65% at 25.04 Hong Kong dollars, with a trading volume of 17.8845 million Hong Kong dollars.
On the news front, ZYLOXTB recently announced a profit increase. It is expected that the net profit for the full year of 2025 will exceed 240 million yuan, an increase of approximately 139.4% compared to the same period last year; and the operating income will exceed 1.05 billion yuan, a year-on-year increase of about 34.6%. ZYLOXTB stated that the company's performance in 2025 is outstanding, mainly due to the strong growth in sales of core products, accelerated development of overseas business, and continuous optimization of operational efficiency.
During the reporting period, the company's sales revenue of products such as Tongqiao Qilin blood flow guiding device, neurovascular guidewire, UltraFree drug-eluting PTA balloon dilatation catheter, and ZYLOX Swan venous intraluminal radiofrequency closure catheter all achieved rapid growth. In terms of international business, the company's overseas market sales revenue increased by over 100% year-on-year, with penetration rates in key markets such as Germany, France, and Italy continuing to rise. At the same time, the company's internationalization strategy achieved key breakthroughs, with comprehensive acceleration in overseas market expansion.
Related Articles

Yum China (09987) spent 773.98 million Hong Kong dollars to repurchase 20,100 shares on February 2nd.

As of the end of January, Lens Technology (06613) has repurchased approximately 7.4096 million A-shares.

Shanxi Install (02520) and Shanghai Jingyu have reached a joint venture agreement with Shanxi Infrastructure to establish a joint venture company to invest in a BOO project.
Yum China (09987) spent 773.98 million Hong Kong dollars to repurchase 20,100 shares on February 2nd.

As of the end of January, Lens Technology (06613) has repurchased approximately 7.4096 million A-shares.

Shanxi Install (02520) and Shanghai Jingyu have reached a joint venture agreement with Shanxi Infrastructure to establish a joint venture company to invest in a BOO project.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


